{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:09:25Z","timestamp":1778807365578,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,14]]},"DOI":"10.7759\/cureus.108860","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:15:27Z","timestamp":1778804127000},"source":"Crossref","is-referenced-by-count":0,"title":["Anabolic Steroid-Induced Cholestatic Jaundice in a Young Adult: An Emerging Clinical Challenge Underscoring the Importance of a Thorough Drug History"],"prefix":"10.7759","author":[{"given":"Min Kyaw","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winluck","family":"Shayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaw Thant","family":"Lwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe Thazin","family":"Aung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27514","article-title":"Anabolic steroid-induced cholestatic liver injury: a case report","volume":"14","author":"Qasim Agha O","year":"2022","unstructured":"Qasim Agha O, Al Hennawi H, Alani M, Aslam S, Reynolds J. Anabolic steroid-induced cholestatic liver injury: a case report. Cureus. 2022, 14:e27514. 10.7759\/cureus.27514","journal-title":"Cureus"},{"key":"ref2","article-title":"Testosterone treatments: why, when, and how?","volume":"73","author":"Margo K","year":"2006","unstructured":"Margo K, Winn R. Testosterone treatments: why, when, and how?. Am Fam Physician. 2006, 73:1591-8.","journal-title":"Am Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1249\/01.mss.0000210194.56834.5d","article-title":"Anabolic androgenic steroids: a survey of 500 users","volume":"38","author":"Parkinson AB","year":"2006","unstructured":"Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006, 38:644-51. 10.1249\/01.mss.0000210194.56834.5d","journal-title":"Med Sci Sports Exerc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/14659891.2014.911977","article-title":"A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: motives, beliefs and experiences","volume":"20","author":"Kim Erg\u00e5rd A","year":"2014","unstructured":"Kim Erg\u00e5rd A, McVeigh J. A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: motives, beliefs and experiences. J Subst Use. 2014, 20:288-94. 10.3109\/14659891.2014.911977","journal-title":"J Subst Use"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid-induced hypogonadism: diagnosis and treatment","volume":"101","author":"Rahnema CD","year":"2014","unstructured":"Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014, 101:1271-9. 10.1016\/j.fertnstert.2014.02.002","journal-title":"Fertil Steril"},{"key":"ref6","article-title":"Long-term effects on the liver","volume":"9","author":"Scheuer PJ","year":"1975","unstructured":"Scheuer PJ. Long-term effects on the liver. J Clin Pathol Suppl (R Coll Pathol). 1975, 9:71-4.","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i26.3071","article-title":"Anabolic androgenic steroid-induced liver injury: an update","volume":"28","author":"Petrovic A","year":"2022","unstructured":"Petrovic A, Vukadin S, Sikora R, et al.. Anabolic androgenic steroid-induced liver injury: an update. World J Gastroenterol. 2022, 28:3071-80. 10.3748\/wjg.v28.i26.3071","journal-title":"World J Gastroenterol"},{"key":"ref8","article-title":"Roussel Uclaf Causality Assessment Method (RUCAM) in drug induced liver injury","year":"2019","unstructured":"Roussel Uclaf Causality Assessment Method (RUCAM) in drug induced liver injury. LiverTox\u00ae. Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD); 2019."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-200434080-00003","article-title":"Effects of androgenic-anabolic steroids in athletes","volume":"34","author":"Hartgens F","year":"2004","unstructured":"Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004, 34:513-54. 10.2165\/00007256-200434080-00003","journal-title":"Sports Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.csmr.0000306529.74500.f6","article-title":"The effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glands","volume":"5","author":"Modlinski R","year":"2006","unstructured":"Modlinski R, Fields KB. The effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glands. Curr Sports Med Rep. 2006, 5:104-9. 10.1097\/01.csmr.0000306529.74500.f6","journal-title":"Curr Sports Med Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12216","article-title":"Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1\/ABCB11 mutations?","volume":"33","author":"El Sherrif Y","year":"2013","unstructured":"El Sherrif Y, Potts JR, Howard MR, Barnardo A, Cairns S, Knisely AS, Verma S. Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1\/ABCB11 mutations?. Liver Int. 2013, 33:1266-70. 10.1111\/liv.12216","journal-title":"Liver Int"},{"key":"ref12","article-title":"Medical issues associated with anabolic steroid use: are they exaggerated?","volume":"5","author":"Hoffman JR","year":"2006","unstructured":"Hoffman JR, Ratamess NA. Medical issues associated with anabolic steroid use: are they exaggerated?. J Sports Sci Med. 2006, 5:182-93.","journal-title":"J Sports Sci Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2015.51376","article-title":"Severe intrahepatic cholestasis and liver failure after stanozolol usage - case report and review of the literature","volume":"1","author":"St\u0119pie\u0144 PM","year":"2015","unstructured":"St\u0119pie\u0144 PM, Reczko K, Wieczorek A, Zar\u0119bska-Michaluk D, Pabjan P, Kr\u00f3l T, Kryczka W. Severe intrahepatic cholestasis and liver failure after stanozolol usage - case report and review of the literature. Clin Exp Hepatol. 2015, 1:30-3. 10.5114\/ceh.2015.51376","journal-title":"Clin Exp Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440163-anabolic-steroid-induced-cholestatic-jaundice-in-a-young-adult-an-emerging-clinical-challenge-underscoring-the-importance-of-a-thorough-drug-history","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:15:28Z","timestamp":1778804128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440163-anabolic-steroid-induced-cholestatic-jaundice-in-a-young-adult-an-emerging-clinical-challenge-underscoring-the-importance-of-a-thorough-drug-history"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.108860","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}